Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03111147 · ClinicalTrials.gov registry record · NA
Impact of Humeral Component Version on Outcomes Following RTSA
A NA study, sponsored by Corewell Health East.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT03111147 is a NA study that has completed, run by Corewell Health East. The registered enrollment target is 95 participants.
The verdict
NCT03111147, a NA study, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
The proposed study is a prospective, single-blinded, randomized trial to investigate the impact of humeral component version on shoulder range of motion and patient reported functional outcomes following reverse total shoulder arthroplasty.
Interventions
- DEVICE 0 degrees humeral component version
- DEVICE 30 degrees humeral component retroversion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2017-05-12 |
| Est. Completion | 2023-05-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03111147
The ClinicalTrials.gov registry entry for NCT03111147 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 0 degrees humeral component version is the first listed.
NCT03111147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03111147 about?
NCT03111147 is a clinical study titled "Impact of Humeral Component Version on Outcomes Following RTSA". The proposed study is a prospective, single-blinded, randomized trial to investigate the impact of humeral component version on shoulder range of motion and patient reported functional outcomes following reverse total shoulder arthroplasty.
What is the current status of trial NCT03111147?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2017-05-12. Estimated completion is 2023-05-23.
What interventions are being tested in trial NCT03111147?
The interventions under investigation include: 0 degrees humeral component version (DEVICE), 30 degrees humeral component retroversion (DEVICE).
Who is sponsoring clinical trial NCT03111147?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.